It took Barney Graham, Jason Mclellan and their collaborators just a weekend in January 2020 to design a novel vaccine they believed would be capable of protecting people against COVID-19. Their design formed the basis for the vaccines that Moderna, Pfizer and others would eventually use to inoculate millions of Americans a little more than a year later, a pace of development unprecedented in the annals of modern medicine.
By then, however, the two pioneering virologists were already thinking about future pandemics— and how they might get ahead of them.
Graham and McLellan are part of a corps of researchers hoping to take the technology they used on COVID-19 vaccines and apply them to an even more futuristic creation: an arsenal of off-the-shelf premade vaccines that could be easily modified to attack new pathogens as they arise—a kind of “pan” or “universal” coronavirus vaccine capable of protecting against many different strains of the virus at the same time.
Even as scientists race to develop booster shots and tweak existing vaccines to work against new variants to SARS2, they’re looking ahead to future pandemics caused by entirely new pathogens from the same coronavirus family, one of just 26 known to infect humans. But SARS-CoV-2 is the third novel, deadly coronavirus to cross over from animals to humans in the last 20 years, and many scientists warn more will inevitably follow. Even though a “universal” vaccine that can protect against any new coronavirus that nature throws at us probably won’t be available this year or next, development has become a high priority.
Diese Geschichte stammt aus der May 21 - 28, 2021 (Double Issue)-Ausgabe von Newsweek.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der May 21 - 28, 2021 (Double Issue)-Ausgabe von Newsweek.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
John David Washington
FOR JOHN DAVID WASHINGTON, BRINGING NETFLIX'S THE PIANO LESSON (November 22) from stage to screen was a family affair.
A Walk in the Parks
Jim O'Heir shares his memories of the hit NBC mockumentary and its cast's hopes of a reunion
Philomena Cunk
PHILOMENA CUNK IS JUST AS SURPRISED AS anyone else at her own popularity.
SOLVING THE PLASTIC PROBLEM
PLASTIC WASTE IS HARMING ANIMALS AND OUR PLANET. CAN THE DAMAGE BE UNDONE?
'I Was Struck by How Humbled and Insignificant I Felt'
An explorer says coming face-to-face in the wild with a grizzly and her cubs changed his perspective on life
Has AI Turned On Health Care?
Hospitals hoped artificial intelligence would lighten their staff's workload, but the same tech could be to blame as insurance firms increasingly deny Medicare Advantage claims
The Next Phase of War
After thousands of elite soldiers from North Korea joined Vladimir Putin’s forces against Ukraine, how has this latest move affected the conflict?
Saying No to Trump and Men
The election has led some women to boycott relationships and sex
My Fight for Equality and Justice
It will take more than just science to end AIDS. Inclusion, empathy and compassion are essential, too
NEW WORLD ORDER
HOW LEADERS ACROSS THE GLOBE ARE REACTING TO DONALD TRUMP'S REELECTION AS U.S. PRESIDENT